Clinical Study of Use of Remdesivir and Tocilizumab in Severely Ill COVID-19 Patients
IntroductionRemdesivir and Tocilizumab are two experimental drugs used in severely ill COVID-19 patients. Various clinical trials studying these drugs are giving conflicting results. Our aim is to study these two drugs and share the experience in our setting. MethodsOur Study is a retrospective anal...
Gespeichert in:
Veröffentlicht in: | Journal of the Association of Physicians of India 2021-07, Vol.69 (7), p.14-19 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!